Education
About Us
Working with TipRanks
Follow Us
RaQualia Pharma Inc. (JP:4579)
:4579
Total Valuation
RaQualia Pharma Inc. has a market cap or net worth of ¥24.73B. The enterprise value is ¥24.09B.
Market Cap¥24.73B
Enterprise Value¥24.09B
Share Statistics
RaQualia Pharma Inc. has 24,458,673 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,458,673
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RaQualia Pharma Inc.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.07%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.07%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee62.19M
Profits Per Employee4.27M
Employee Count64
Asset Turnover0.38
Inventory Turnover4.46
Valuation Ratios
The current PE Ratio of RaQualia Pharma Inc. is 87.4. RaQualia Pharma Inc.’s PEG ratio is -0.58.
PE Ratio87.4
PS Ratio6.01
PB Ratio3.47
Price to Fair Value3.47
Price to FCF-56.43
Price to Operating Cash Flow-65.87
PEG Ratio-0.58
Income Statement
In the last 12 months, RaQualia Pharma Inc. had revenue of 3.98B and earned 273.12M in profits. Earnings per share was 11.53.
Revenue3.98B
Gross Profit3.27B
Operating Income483.72M
Pretax Income437.95M
Net Income273.12M
EBITDA971.88M
Earnings Per Share (EPS)11.53
Cash Flow
In the last 12 months, operating cash flow was -356.63M and capital expenditures -67.35M, giving a free cash flow of -423.98M billion.
Operating Cash Flow-356.63M
Free Cash Flow-423.98M
Free Cash Flow per Share-17.33
Dividends & Yields
RaQualia Pharma Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change133.96%
50-Day Moving Average1.04K
200-Day Moving Average714.12
Relative Strength Index (RSI)45.68
Average Volume (3m)352.93K
Important Dates
RaQualia Pharma Inc. upcoming earnings date is May 20, 2026, TBA (Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
RaQualia Pharma Inc. as a current ratio of 4.46, with Debt / Equity ratio of 42.08%
Current Ratio4.46
Quick Ratio4.33
Debt to Market Cap0.11
Net Debt to EBITDA-0.35
Interest Coverage Ratio8.19
Taxes
In the past 12 months, RaQualia Pharma Inc. has paid 164.83M in taxes.
Income Tax164.83M
Effective Tax Rate0.38
Enterprise Valuation
RaQualia Pharma Inc. EV to EBITDA ratio is 24.27, with an EV/FCF ratio of -55.63.
EV to Sales5.93
EV to EBITDA24.27
EV to Free Cash Flow-55.63
EV to Operating Cash Flow-66.14
Balance Sheet
RaQualia Pharma Inc. has ¥3.24B in cash and marketable securities with ¥2.90B in debt, giving a net cash position of ¥342.38M billion.
Cash & Marketable Securities¥3.24B
Total Debt¥2.90B
Net Cash¥342.38M
Net Cash Per Share¥14.00
Tangible Book Value Per Share¥133.54
Margins
Gross margin is 76.90%, with operating margin of 12.15%, and net profit margin of 6.86%.
Gross Margin76.90%
Operating Margin12.15%
Pretax Margin11.00%
Net Profit Margin6.86%
EBITDA Margin24.42%
EBIT Margin12.15%
Analyst Forecast
The average price target for RaQualia Pharma Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.87%
EPS Growth Forecast-24.41%